These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 8794893

  • 1. Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.
    Yu H, Cai JJ, Lee HC.
    Mol Pharmacol; 1996 Sep; 50(3):549-55. PubMed ID: 8794893
    [Abstract] [Full Text] [Related]

  • 2. Protein kinase C isozyme-specific modulation of cyclic AMP-dependent phosphodiesterase in hypertrophic cardiomyopathic hamster hearts.
    Cai JJ, Lee HC.
    Mol Pharmacol; 1996 Jan; 49(1):81-8. PubMed ID: 8569716
    [Abstract] [Full Text] [Related]

  • 3. Effect of protein kinase C on cyclic 3',5'-adenosine monophosphate-dependent phosphodiesterase in hypertrophic cardiomyopathic hamster hearts.
    Lee HC, Cai JJ, Yu H.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1171-6. PubMed ID: 7932168
    [Abstract] [Full Text] [Related]

  • 4. Changes in cyclic nucleotide phosphodiesterase activity and calmodulin concentration in heart muscle of cardiomyopathic hamsters.
    Masunaga R, Nagasaka A, Sawai Y, Hayakawa N, Nakai A, Hotta K, Kato Y, Hishida H, Takahashi H, Naka M, Shimada Y, Tanaka T, Hidaka H, Itoh M.
    J Mol Cell Cardiol; 2004 Sep; 37(3):767-74. PubMed ID: 15350849
    [Abstract] [Full Text] [Related]

  • 5. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ, Cieslinski LB.
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [Abstract] [Full Text] [Related]

  • 6. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
    Bode DC, Hamel LT, Wax MB.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
    [Abstract] [Full Text] [Related]

  • 7. Cellular distribution and pharmacological sensitivity of low Km cyclic nucleotide phosphodiesterase isozymes in human cardiac muscle from normal and cardiomyopathic subjects.
    Silver PJ, Allen P, Etzler JH, Hamel LT, Bentley RG, Pagani ED.
    Second Messengers Phosphoproteins; 1990 Dec; 13(1):13-25. PubMed ID: 2286932
    [Abstract] [Full Text] [Related]

  • 8. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ, Zhou HL, Burman M, Huang LB.
    Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
    [Abstract] [Full Text] [Related]

  • 9. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
    Picq M, Dubois M, Grynberg A, Lagarde M, Prigent AF.
    J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
    [Abstract] [Full Text] [Related]

  • 10. High activity of low-Michaelis-Menten constant 3', 5'-cyclic adenosine monophosphate-phosphodiesterase isozymes in renal inner medulla of mice with hereditary nephrogenic diabetes insipidus.
    Takeda S, Lin CT, Morgano PG, McIntyre SJ, Dousa TP.
    Endocrinology; 1991 Jul; 129(1):287-94. PubMed ID: 1647298
    [Abstract] [Full Text] [Related]

  • 11. [Separation and investigation of the regulatory properties of two forms of cyclic nucleotide phosphodiesterase from rabbit heart--sensitive and insensitive to Ca-dependent regulator protein].
    Tkachuk VA, Lazarevich VG, Men'shikov MIu, Severin SE.
    Biokhimiia; 1978 Sep; 43(9):1622-30. PubMed ID: 214170
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE, Quade MM, Schenden JA, Evans DB.
    J Cyclic Nucleotide Protein Phosphor Res; 1985 Sep; 10(6):551-64. PubMed ID: 3003170
    [Abstract] [Full Text] [Related]

  • 16. Isolation, characterization and Ca2+ and calmodulin regulation of cyclic nucleotide phosphodiesterases from human placentae of different ages.
    Tertrin-Clary C, Chenut MC, Acker G, De La Llosa P.
    Biochem Int; 1989 Jan; 18(1):99-117. PubMed ID: 2541726
    [Abstract] [Full Text] [Related]

  • 17. Immunologic approaches to the study of cyclic nucleotide phosphodiesterases.
    Hurwitz RL, Hansen RS, Harrison SA, Martins TJ, Mumby MC, Beavo JA.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Jan; 16():89-106. PubMed ID: 6326539
    [Abstract] [Full Text] [Related]

  • 18. Resolution of soluble rat cardiac phosphodiesterases by high performance liquid chromatography.
    Bode DC, Kanter JR, Brunton LL.
    Second Messengers Phosphoproteins; 1984 Jan; 12(5-6):235-40. PubMed ID: 2856111
    [Abstract] [Full Text] [Related]

  • 19. [3',5'-cyclic nucleotide phosphodiesterase from human brain].
    Bobruskin ID, Muratova MV, Kireeva NN, Belov AA, Severin ES.
    Biokhimiia; 1989 Sep; 54(9):1499-507. PubMed ID: 2556185
    [Abstract] [Full Text] [Related]

  • 20. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
    Sutor B, Mantell K, Bacher B.
    Neurosci Lett; 1998 Aug 07; 252(1):57-60. PubMed ID: 9756358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.